Issue №5-99, 2020

Original article

https://doi.org/10.38025/2078-1962-2020-99-5-94-100

Ozone Therapy in Patients with the New Coronavirus Infection COVID-19

View article (Download PDF file)



Download XML file

1 ORCIDHammad E.V., 1 ORCIDNikitin I.G., 1 ORCIDFedorova K.V.

1 National Medical Research Center «Treatment and Rehabilitation Center», Moscow, Russian Federation


ABSTRACT

Aim. In our work we seek to develop new approaches for treating patients with COVID-19. The first reports about new coronavirus infection, COVID-19, came out in China in 2019. It was recognized by WHO as a pandemic crisis on March 11, 2020. Currently, there is no standard therapy protocol for COVID-19 and the drugs are used off label.

Material and methods. We have implemented ozone therapy into clinical practice as an adjuvant treatment regimen for patients with SARS-CoV-2 infection. In our study, 19 patients received ozone therapy and 18 patients were members of the control group. All patients had a positive PCR test for SARS-CoV-2 infection and were matched by the following features: sex, age, severity of symptoms, imaging data and clinical history. Patients in the study group received ozone therapy in the form of daily intravenous infusions of ozonized physiological solution (concentration: 2.2-2.4 mg/l).

Conclusion. We observed a statistically significant improvement in laboratory, radiological and clinical tests of patients in the study group compared to the control group on the 14th day. Thus, we have demonstrated the benefits of using ozone therapy in patients with the new coronavirus infection COVID-19. Taking into consideration the physiological processes underlying such approach, ozone therapy should be justified for both phases: the beginning and at the peak of the disease.



KEYWORDS: new coronavirus infection COVID-19, ozone therapy

For citation: Hammad E.V., Nikitin I.G., Fedorova K.V. Ozone therapy in Patients with the New Coronavirus Infection COVID-19. Bulletin of Rehabilitation Medicine. 2020; 5 (99): 94-100. https://doi.org/10.38025/2078-1962-2020-99-5-94-100



References:

  1. Vremennye metodicheskie rekomendacii profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19). Ministerstvo Zdravoohraneniya Ros-sijskoj Federacii. Versiya 6 [Temporary guidelines for prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Ministry of Health of the Russian Federation]. (28.04.2020) (In Russ.).
  2. Zinchuk V. V., Bileckaya E. S. Kislorodzavisimye mekhanizmy fiziologicheskogo dejstviya ozona (obzor) [Oxygen-dependent mechanisms of the physiological action of ozone (review)]. Zhurnal mediko-biologicheskih issledovanij. 2019; V.7 (2): 216-227 (In Russ.).
  3. Alenina N., Bader M. ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models. Neurochemical Research. 2019; 44 (6): 1323-1329. DOI:10.1007/s11064-018-2679-4
  4. Conti P., Ronconi G., Caraffa A. et al. Induction of proinflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. Journal of Biological Regulators and Homeostatic Agents. 2020; 34 (2): 1 p. DOI:10.23812/CONTI-E
  5. Zaky S., Kamel S. E., Hassan M. S. et al. Preliminary results of ozone therapy as a possible treatment for patients with chronic hepatitis C. Journal of Alternative and Complementary Medicine. 2011; 17 (3): 259-263. DOI:10.1089/acm.2010.0016
  6. Zanardi I., Borrelli E., Valacchi G., Travagli V., Bocci V. Ozone: A Multifaceted Molecule whith Unexpected Therapeutic Activity. Current Medicinal Chemistry. 2016; 23 (4): 304-314. DOI: 10.2174/0929867323666151221150420
  7. Martinez-Sanchez G., Schwartz A., Donna V. D. Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19. Antioxidants. 2020; 9 (5): 389 p. DOI:10.3390/antiox9050389
  8. Lukin V. V., Popovich M. P., Tkachenko S. N. Fizicheskaya himiya ozona [Physical chemistry of ozone]. Izd. MGU. 1998: 480 p. (In Russ.).
  9. Kontorshchikova, K. I., Obuhov L. I., Sibirkin A. L. Molekulyarnye produkty razlozheniya ozona v vodnyh rastvorah [Molecular products of ozone decomposition in aqueous solutions]. Bioradikaly i Antioksidanty. 2015; 1 (V.2): 45-53 (In Russ.).
  10. Istoriya razvitiya ozonoterapii v mire [The history of the development of ozone therapy in the world]. Available at: http://ozonetherapy.ru (Accessed: 25.05.20) (In Russ.).
  11. Yarustovskaya O. V., Kulikov A. G., Shtro L. P. Ozonoterapiya kak effektivnyj komponent kompleksnogo lecheniya bol’nyh bakterial’nym vaginozom [Ozone therapy as an effective component in the comprehensive treatment of patients with bacterial vaginosis].Voprosy kurortologii, fizioterapii i lech-ebnoj fizicheskoj kul’tury. 2015; 92 (5): 45-49. DOI:10.17116/kurort2015545-49 (In Russ.).
  12. Valacchi G., Sticozzi C., Zanardi I. et al. Ozone mediators effect on “in vitro” scratch wound closure. Free Radical Research. 2016; 50 (9): 1022-1031. DOI:1 0.1080/10715762.2016.1219731
  13. Zaky S., Kamel S. E., Hassan M. S. et al. Preliminary results of ozone therapy as a possible treatment for patients with chronic hepatitis C. Journal of Alternative and Complementary Medicine. 2011; 17 (3): 259-263. DOI:10.1089/acm.2010.0016
  14. Gulieva M. G., Zeynalova E. I., Figarova N. A., Rafiev F. D. Ozonoterapiya [Ozone Therapy]. Oftal’mologiya, 2010; (2): 102-109 (In Russ.).
  15. Tairov. I. N., Fazylov V. H., Galeeva N. V. et al. Ozonoterapiya kak metod metabolicheskoj korrekcii pri sal’monelleze. Aktual’nye problemy infekcionnoj patologii, posvyashchennoj 85-letiyu kafedry infekcionnyh boleznej i epidemiologii Sibirskogo gosudarstvennogo medicinskogo universiteta [Ozone therapy as a method of metabolic correction for salmonellosis. Current problems of infectious pathology, dedicated to the 85th anniversary of the Department of Infectious Diseases and Epidemiology at the Siberian State Medical University.]. Tomsk. 2009: 161 p. (In Russ.).
  16. Shcherbatyuk T. G. Sovremennoe sostoyanie ozonoterapii v medicine. Perspektivy primeneniya v onkologii [Current state of ozone therapy in Russia medicine. Prospects for use in Oncology]. Sovremennye tekhnologii v medicine. 2010; (1): 99-106 (In Russ.).
  17. Carpendale M. T., Freeberg J.K. Ozone inactivates HIV at noncytotoxic concentrations. Antiviral Research. 1991; 16 (3): 281-292. DOI:10.1016/0166-3542 (91)90007-e
  18. Dorstewitz H. Proceedings of the 9-th ozone world congress «Ozone in medicine». New York. 1989: 17-22.
  19. Bocci V., Zanardia I., Valacchi G., Borrelli E., Travagli V. Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases. Cardiovascular & Hematological Disorders-Drug Targets. 2015; 15 (2): 127-138. DOI:10.2174/1871529x1502151209114642
  20. Bocci V., Valacchi G. Nrf2 activation as target to implement therapeutic treatments. Frontiers in Chemistry. 2015; (3): 4 p. DOI:10.3389/fchem.2015.00004
  21. Fazylov V. H., Galeeva N. V., Zagidullina A. I., Tairov I.N. Ozonoterapiya v klinike infekcionnyh boleznej [Ozone therapy in the clinic of infectious diseases]. Prakticheskaya medicina. 2013; (5): 47-51 (In Russ.).
  22. Ryser H., Levy E., Mandel R., Disciullo G. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proceedings of the National Academy of Sciences. 1994; (91): 4559-4563.
  23. Mirazimi A., Mousavi-Jazi M., Sundqvist V. A., Svensson L. Free thiol groups are essential for infectivity of human cytomegalovirus. Journal of General Virology. 1999; (80): 2861-2865.
  24. Klassifikaciya pacientov s podozreniem na inficirovanie koronovirusom COVID-19 (CO-RADS) [Classification of patients with suspected covind-19 coronavirus infection (CO-RDS)]. Available at: http://mibsnews.ru (Accessed: 25.05.20)
  25. Boyarinov G.A. The solubility of ozone in physiological solution]. Materialy III Vserossijskoj nauchno-prakticheskoj konferencii “Ozon i metody efferentnoj terapii v medicine” [III Russian scientific and practical conference “Ozone and methods of efferent therapy in medicine”]. N. Novgorod. 1998: 6-9 (In Russ.).
  26. Klassifikaciya stepeni tyazhesti virusnoj/COVID-19 pnevmonii po KT [Classification of the severity of viral/COVID-19 pneumonia by CT]. Available at: http://www.secondopinions.ru (Accessed: 27.05.20)
  27. Protokol ocenki tyazhesti sostoyaniya pacienta (NEWS). Terapevticheskij profil’ [Protocol for assessing the severity of the patient’s condition (NEWS). Therapeutic profile]. Available at: http://www.euat.ru (Accessed: 28.05.20)
  28. Gospital’naya shkala trevogi i depressii [Hospital scale of anxiety and depression]. Available at: http://www.psylab.info (Accessed: 28.05.20).



Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©

Эта статья открытого доступа по лицензии CC BY 4.0. Издательство: ФГБУ «НМИЦ РК» Минздрава России.
This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.